Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Indications for Tirzepatide Tirzepatide is primarily indicated for the management of type 2 diabetes, marketed under the brand name Mounjaro
As the first approved dual agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor, it achieves glycemic control and weight loss outcomes that exceed those of selective GLP-1 receptor agonists alone
With regular use, youll notice your skin becoming more supple and youthful, while also supporting stronger nails and shinier hair
Ideal for those pursuing an active lifestyle and looking to optimize their nutritional support
Coffee-friendly combo Grande Caff Latte with no syrup + Egg White Egg Bites This gives protein from both milk and egg bites without relying on a sweet drink
or 31.9 kg - 45.3% of patients hit 30%+ weight loss (this is bariatric surgery territory) - 30.3% weight loss (85 lbs) at 104 weeks in higher-BMI patients - 65.3% of 12mg patients dropped below the obesity BMI threshold - 19% loss on 4mg over 80 weeks (47.2 lbs) with fewer dropouts than placebo (4.1% vs 4.9%) - significant drops in blood pressure, triglycerides, non-HDL cholesterol, waist circumference, and hsCRP - no cardiac or liver signals Retatrutide is going to completely overshadow tirzepatide and semaglutide, and take the throne as the best-selling drug of all time
US$ 24.45
US$ 23.92
US$ 24.13
US$ 28.86
